Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Online ‘Biclustering’ Tool Stratifies Patients To The Molecular Level

    Aug 9, 2022, 01:00 AM by User Not Found
    Bio-IT World | Researchers in Germany have developed a web-based tool, powered by machine learning, which extracts disease subtypes from large pools of patient data. The goal is more precise and robust predictions about molecular signatures that can serve as a starting point for investigating disease heterogeneity.
    Full story
  • BioIVT Acquires Cypex, a Leading Manufacturer of Drug-metabolizing Enzymes

    Aug 8, 2022, 10:15 AM by
    Cypex’s recombinant xenobiotic metabolizing enzymes complement BioIVT’s extensive portfolio of hepatocytes and related hepatic products for drug research and development.
    Full story
  • European pharma needs to keep manufacturing on the continent and become more digitised to stay competitive, say speakers at new event

    Aug 8, 2022, 10:14 AM by
    The newly announced agenda for Connect in Pharma focuses on innovation as the foundation of a strong pharmaceutical industry in Europe. In order to ensure a strong future for European pharma, businesses need to prioritise digitalisation and maintain control of production lines, say two speakers due to present at the Geneva-based event in September.
    Full story
  • Service Portfolio Expanded for Drug Delivery Research

    Aug 5, 2022, 09:14 AM by
    Full story
  • How Deleted and Siloed Data Are Slowing Discovery

    Aug 5, 2022, 01:00 AM by User Not Found
    Bio-IT World | Though advancements in instruments and software have driven life sciences breakthroughs that drastically improve global health outcomes, researchers still struggle to maximize the value of the huge datasets that these high-throughput technologies generate. Currently, two common practices stand in the way of good data management at many life sciences institutions.
    Full story
  • Antibiotic Research UK Announces New CEO

    Aug 4, 2022, 09:37 AM by
    The charity Antibiotic Research UK welcomes Jonathan Pearce as the new CEO, effective 1 August 2022. He takes over the position from founder Professor Colin Garner, who retired at the end of July 2022.
    Full story
  • Trace Metal Analysis: An Established Technique Driving Advances in Alternative Energy Materials

    Aug 4, 2022, 09:36 AM by
    Full story
  • Peptides for Diabetes Research—a Special Offer of BOC Sciences

    Aug 3, 2022, 09:36 AM by
    BOC Sciences has been constantly enriching its peptide product library for years. Its peptides for diabetes research are recently brought into focus due to the growing concerns on this problem.
    Full story
  • Stable and Quality Supply of Phosphoramidites Is a Reality at BOC Sciences

    Aug 3, 2022, 09:35 AM by
    As an expert in chemistry, BOC Sciences understands how important the quality of phosphoramidite is to successful oligo synthesis and remarkably, it has taken concrete actions to manufacture certified products.
    Full story
  • BOC Sciences Shares Its Strategic Emphasis on NTPs during the Pandemic

    Aug 3, 2022, 09:34 AM by
    "Whether your studies involve DNA sequencing, cDNA synthesis, RT-PCR, RCA, MDA, DNA labeling, in vitro transcription, siRNA synthesis, or RNA amplification, we stock hundreds of modified or natural NTPs to suit your various molecular biological applications," a BOC Sciences manager announces to the public.
    Full story
  • Vaxess Announces Launch of Phase 1 Trial For H1 Influenza Vaccine Patch

    Aug 3, 2022, 09:31 AM by
    Company focused on creating shot-free future of vaccines; first human trial of Vaxess MIMIX™ vaccine patch will focus on administering influenza vaccine
    Full story
  • Bio-IT World Announces European Best of Show Awards

    Aug 3, 2022, 01:00 AM by User Not Found
    Bio-IT World | Bio-IT World is bringing the Best of Show competition to Europe this fall at the Bio-IT World Conference & Expo Europe in Berlin, October 18-19.
    Full story
  • Lyniate Merges with CareCom, Further Extending Capabilities of Interoperability Leader

    Aug 2, 2022, 09:39 AM by
    Full story
  • Creative Biogene Launches Zebrafish Disease Models to Support Drug Discovery and Toxicology Research

    Aug 2, 2022, 09:38 AM by
    Full story
  • IntegrateRNA Launches GalNAc-Oligonucleotide Conjugation Service to Support Oligonucleotides Therapeutic Research

    Aug 2, 2022, 09:37 AM by
    Full story
  • MicroRNA Agomir Synthesis: Supporting New Drug Research with Cutting-Edge Chemical Synthesis Technology

    Aug 2, 2022, 09:36 AM by
    Full story
  • Creative Bioarray Offers Clonality Analysis Service to Accelerate Biopharmaceutical or Biosimilar Development

    Aug 2, 2022, 09:35 AM by
    Full story
  • Creative Bioarray Develops Full-service Support for Transgene Mapping

    Aug 2, 2022, 09:35 AM by
    Full story
  • Creative Bioarray Has Developed Cell Immortalization Services to Support Potential Drug Development

    Aug 2, 2022, 09:34 AM by
    Full story
  • GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine

    Aug 2, 2022, 09:34 AM by
    GreenLight Biosciences and Samsung Biologics announce successful completion of the first commercial-scale engineering run for the companies' mRNA production partnership
    Full story
  • «
  • 121 (current)
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy